DHFR MEDIATED ANTIFOLATE RESISTANCE IN MAMMALIAN CELLS

哺乳动物细胞中 DHFR 介导的抗叶酸耐药性

基本信息

  • 批准号:
    3193708
  • 负责人:
  • 金额:
    $ 19.26万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1990
  • 资助国家:
    美国
  • 起止时间:
    1990-05-01 至 1995-02-28
  • 项目状态:
    已结题

项目摘要

The wide use of the antifolate drug methotrexate (NM) as a chemotherapeutic agent requires that knowledge of its target enzyme, dihydrofolate reductase (DHFR), be extensive and that the enzymes' biochemical and genetic characteristics be understood. Moreover, since the effectiveness of MTX is often comprimised by intrinsic or acquired resistance, a better understanding of the mechanism(s) of such resistance might provide insights into more effective treatment protocols. It has been found that the Chinese hamster lung cell line DC-3F is heterozygous at the DHFR locus and contains 2 polymorphic DHFR alleles. Among 58 independently derived, gene amplification mediated DHFR overproducing MTX-resistant sublines, 44 amplify and overexpress one of the 2 allelic forms of DHFR and 14 the other. Since gene amplification is thought to be a random phenomenon, one of the goals of this proposal is to determine, by use of pulse field gel electrophoresis, Southern blotting and cDNA transfection analysis, the genetic basis for the observed differential allelic amplification. In addition, recent determination that commonly observed minor isoelectric forms of DHFR (which can account for 10-15% of the cellular enzyme) are derived by N-terminal acetylation of the major DHFR proteins, suggests that these forms may serve a specific biological function. With a combination of NM-affinity column and isoelectrofocusing purification techniques, enzyme kinetic analysis and monoclonal antibody preparation for immunocytochemical detection we propose to clarify the biological significance of those long recognized but poorly understood DHFRS.
抗叶酸药物甲氨蝶呤(NM)作为化疗药物的广泛使用 药剂需要知道其靶酶二氢叶酸还原酶 (DHFR),是广泛的,酶的生化和遗传 特点要理解。此外,由于MTX的有效性是 通常被内在或后天的抵抗力所困扰, 了解这种耐药性的机制可能有助于了解 更有效的治疗方案据了解,中国人 仓鼠肺细胞系DC-3F在DHFR基因座处是杂合的,并且含有 2个多态性DHFR等位基因。在58个独立衍生的基因中, 扩增介导的DHFR过度产生MTX耐药亚系,44 扩增并过表达DHFR的2种等位基因形式之一, 其他.由于基因扩增被认为是一种随机现象, 该建议的目标之一是通过使用脉冲场凝胶 电泳、Southern印迹和cDNA转染分析, 观察到的差异等位基因扩增的遗传基础。在 此外,最近的测定表明, DHFR的形式(可占细胞酶的10-15%)是 由主要DHFR蛋白的N-末端乙酰化衍生,表明, 这些形式可能具有特定的生物学功能。的组合 纳米亲和柱和等电聚焦纯化技术,酶 免疫细胞化学动力学分析及单克隆抗体制备 检测,我们建议澄清这些长期的生物学意义 公认但了解甚少的DHFRS。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter William Melera其他文献

Peter William Melera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter William Melera', 18)}}的其他基金

DHFR MEDIATED ANTIFOLATE RESISTANCE IN MAMMALIAN CELLS
哺乳动物细胞中 DHFR 介导的抗叶酸耐药性
  • 批准号:
    3193707
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    2442974
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    2093333
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
DHFR MEDIATED ANTIFOLATE RESISTANCE IN MAMMALIAN CELLS
哺乳动物细胞中 DHFR 介导的抗叶酸耐药性
  • 批准号:
    3193706
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    6076209
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    6489098
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
DHFR MEDIATED ANTIFOLATE RESISTANCE
DHFR 介导的抗叶酸耐药性
  • 批准号:
    2093330
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    2733001
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
DHFR MEDIATED ANTIFOLATE RESISTANCE IN MAMMALIAN CELLS
哺乳动物细胞中 DHFR 介导的抗叶酸耐药性
  • 批准号:
    3193709
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:
REDUCED FOLATE TRANSPORT AND ANTIFOLATE RESISTANCE
减少叶酸转运和抗叶酸抗药性
  • 批准号:
    6341919
  • 财政年份:
    1990
  • 资助金额:
    $ 19.26万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 19.26万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 19.26万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 19.26万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 19.26万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 19.26万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 19.26万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 19.26万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 19.26万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 19.26万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 19.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了